|
PPP4R1L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.625100E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.022900E-03 |
| Normal-vs-Stage2 |
1.096790E-01 |
| Normal-vs-Stage3 |
3.676600E-01 |
| Normal-vs-Stage4 |
2.648400E-02 |
| Stage1-vs-Stage2 |
6.775600E-01 |
| Stage1-vs-Stage3 |
3.710400E-01 |
| Stage1-vs-Stage4 |
1.769840E-04 |
| Stage2-vs-Stage3 |
3.594200E-01 |
| Stage2-vs-Stage4 |
9.183100E-03 |
| Stage3-vs-Stage4 |
1.810240E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.632400E-04 |
| Normal-vs-AfricanAmerican |
3.457500E-02 |
| Normal-vs-Asian |
2.190200E-01 |
| Caucasian-vs-AfricanAmerican |
7.438600E-01 |
| Caucasian-vs-Asian |
1.263620E-02 |
| AfricanAmerican-vs-Asian |
1.694230E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.318100E-03 |
| Normal-vs-Female |
8.617700E-03 |
| Male-vs-Female |
6.192400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.390200E-01 |
| Normal-vs-Extreme_Weight |
6.578500E-02 |
| Normal-vs-Obese |
5.119000E-03 |
| Normal-vs-Extreme_Obese |
6.839600E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.085800E-01 |
| Normal_Weight-vs-Obese |
1.660580E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.966400E-01 |
| Extreme_Weight-vs-Obese |
2.185200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.455400E-01 |
| Obese-vs-Extreme_Obese |
3.154600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.833800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.183300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.830000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.383600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.551800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.404800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.801900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.267600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.243900E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.159900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.93159999999759E-05 |
| Normal-VS-Type2 PRCC |
5.933200E-01 |
| Normal-VS-KIRP CIMP |
7.632600E-01 |
| Normal-VS-Unclassified PRCC |
2.644900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.93060000045031E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.990100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.860970E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.466600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.183010E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
6.138100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.338000E-01 |
| Normal-vs-N1 |
8.543000E-01 |
| Normal-vs-N2 |
2.079600E-01 |
| N0-vs-N1 |
5.215800E-01 |
| N0-vs-N2 |
1.872970E-01 |
| N1-vs-N2 |
4.231600E-01 |
|
|
